Epic Medical Research Joins hyperCORE International to Enhance Global Clinical Trials
TL;DR
Epic Medical Research joining hyperCORE International offers partners access to expanded clinical trial capabilities and a broader platform for innovative solutions.
hyperCORE International integrates Epic Medical Research's 12 locations and specialized labs into its network, enhancing trial performance through shared expertise and operational frameworks.
The partnership between hyperCORE International and Epic Medical Research aims to improve patient outcomes by advancing clinical research across a wide range of therapeutic areas.
Discover how hyperCORE International's new partnership with Epic Medical Research is set to revolutionize clinical trials with cutting-edge facilities and a vast therapeutic reach.
Found this article helpful?
Share it with your network and spread the knowledge!
Epic Medical Research has officially become part of hyperCORE International's global partner site network, a move that significantly enhances the clinical research organization's ability to conduct comprehensive trials across a wide range of therapeutic areas. Based in Dallas, Texas, Epic Medical Research operates 12 state-of-the-art locations across four states, specializing in metabolic disorders, fatty liver disease (NASH), sleep apnea, and more, with advanced facilities including Phase I units and an on-site sleep lab.
Dr. Haresh Boghara, President & Principal Investigator at Epic Medical Research, expressed enthusiasm about the partnership, highlighting the shared commitment to advancing clinical research and improving patient outcomes. The collaboration with hyperCORE International is expected to provide Epic with access to greater resources, shared expertise, and a broader platform for delivering innovative clinical trial solutions.
Nicholas Focil, President of hyperCORE International, welcomed Epic Medical Research into the network, praising their therapeutic breadth and operational scale. This partnership aligns with hyperCORE's mission to enhance trial performance across its global network of clinical research partners, promising streamlined operations and accelerated results in clinical research.
Since its founding in 2019, hyperCORE International has grown to include over 80 active trial sites across five countries and two continents, completing more than 7,000 studies with over 140,000 participants. The network's success is built on harmonized operational frameworks that ensure efficiency, standardization, and excellence in clinical research. With the addition of Epic Medical Research, hyperCORE International continues to advance its commitment to safe, ethical, and timely studies, supported by its members' top-tier awards for performance, quality, and innovation.
For more information on hyperCORE International and its network, visit https://www.hypercoreinternational.com.
Curated from 24-7 Press Release
